Human medicines European public assessment report (EPAR): Strensiq, asfotase alfa, Date of authorisation: 28/08/2015, Revision: 18, Status: Authorised

PSUSA/00003146/202507

PSUSA/00001476/202508

New PRIME tools to accelerate development of medicines in the EU

Opinion on medicine for use outside EU: Mosquirix, RTS,S [Portion of P. falciparum circumsporozoite protein fused with hepatitis B surface antigen (RTS), and combined with hepatitis B surface antigen (S)], Malaria, 23/07/2015 Positive opinion

Network Portfolio Roadmap

Human medicines European public assessment report (EPAR): Cegfila (previously Pegfilgrastim Mundipharma), pegfilgrastim, Date of authorisation: 19/12/2019, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Pelmeg, pegfilgrastim, Date of authorisation: 20/11/2018, Revision: 12, Status: Authorised

Quality Innovation Group

EMA Veterinary Medicines Info Day 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 12 March 2026, 14:00 (CET) to 13 March 2026, 12:30 (CET)